Understanding the Impact of COSMIC-311 and Sequencing in DTC
Marcia Brose, MD, examines data from the COSMIC-311 study, emphasizing the importance of promptly initiating second-line therapy for patients who have progressed on first-line treatments.
Source: onclive.com